Ojocef- S 1.5gm

Product Description

Ojocef-S 1.5 gm Injection contains Ceftriaxone Sodium I.P. 1000 mg and Sulbactam Sodium I.P. 500 mg, a combination antibiotic used for the treatment of moderate to severe bacterial infections, including resistant cases.

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Sulbactam acts as a beta-lactamase inhibitor, enhancing the effectiveness of Ceftriaxone by preventing bacterial resistance. This dual-action formulation provides broad-spectrum antibacterial coverage and improves treatment outcomes.

Key Benefits

• Broad-spectrum antibiotic for serious infections
• Effective against resistant bacterial strains
• Dual action enhances antibacterial efficacy
• Helps control infection and prevent spread
• Promotes faster recovery

Key Ingredients

• Ceftriaxone Sodium I.P. 1000 mg – Cephalosporin antibiotic
• Sulbactam Sodium I.P. 500 mg – Beta-lactamase inhibitor

Indications

• Respiratory tract infections
• Urinary tract infections
• Intra-abdominal infections
• Skin and soft tissue infections
• Gynecological infections
• Septicemia

Dosage / Administration

• Administered via intravenous or intramuscular route
• Dosage as directed by a physician
• Use under strict medical supervision

Precautions

• Use under medical supervision
• Check for cephalosporin or penicillin allergy
• Monitor liver and kidney function
• Not effective in viral infections
• Complete the full course as prescribed
• Store as per label instructions
• Keep out of reach of children

Common side effects may include injection site pain, diarrhea, rash, or nausea. Occasionally, patients may experience elevated liver enzymes or blood count abnormalities. Serious allergic reactions are rare but require immediate medical attention.

Ojocef- S 1.5gm
is indicated for the treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, septicemia, and skin and soft tissue infections. It is also useful in managing complicated hospital-acquired infections where resistance is suspected or confirmed.

Administer only under medical supervision. Dosage should be adjusted in patients with renal impairment. Do not use in individuals with known allergies to cephalosporins or beta-lactam antibiotics. Complete the prescribed course to prevent resistance development.

Store in a cool, dry place between 2°C to 8°C. Protect from light. Reconstitute with sterile water for injection as directed and use immediately after preparation. Keep out of reach of children.